{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:09Z","timestamp":1781643369519,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) remains a global public health concern. Despite the availability of direct-acting antivirals (DAAs), many infections remain undiagnosed\u2014particularly in older adults excluded from national screening programs. This study aimed to assess the prevalence of unrecognized HCV infections in surgical patients over 55 years of age through an opportunistic hospital-based screening approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-center, retrospective observational study was conducted at \u201cFederico II\u201d University Hospital in Naples, Italy, from January 1 to December 31, 2023. All patients aged\u2009\u2265\u200918 years undergoing surgery or hospital admission were screened for anti-HCV antibodies. Reflex testing of samples with a signal-to-cut off (s\/co) ratio\u2009\u2265\u200911 was performed with Elecsys\n                      <jats:sup>\u00ae<\/jats:sup>\n                      HCV Duo assay to confirm active infection via antigen detection. The primary endpoint was the prevalence of undiagnosed active infections in patients over 55. Secondary endpoints included distribution by age, sex, and hospital department.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 33,658 patients screened, 768 (2.3%) tested positive for anti-HCV antibodies; 178 (23.2%) were antigen-positive. Active infections were most common in patients aged 55\u201379 (66%) and \u2265\u200980 (21.7%), with the highest positivity (36.5%) in those over 80. In non\u2013high-risk departments, HCV antigen positivity reached 21.2%. No significant sex differences were observed. All antigen-positive patients received DAA treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Opportunistic screening in surgical patients over 55 is effective, feasible, and cost-efficient. The high rate of undiagnosed infections in this age group supports expanding screening efforts to include older adults. These results support the national implementation of opportunistic screening programs targeting older adults to achieve HCV elimination goals. Further multicenter studies are needed to support broader implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-026-01866-7","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:51:19Z","timestamp":1773809479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering hidden HCV infections in adults over 55: reflex testing and insights for opportunistic screening in a tertiary care setting"],"prefix":"10.1186","volume":"84","author":[{"given":"Emma","family":"Montella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nocerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Del Sorbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Brusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Jannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Pinchera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cossiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"HCV Polaris Observatory","year":"2022","unstructured":"Polaris Observatory HCV, Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study. Lancet Gastroenterol Hepatol. 2022;7:396\u2013415.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1866_CR2","volume-title":"Guidance for country validation of viral hepatitis elimination and path to elimination","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Guidance for country validation of viral hepatitis elimination and path to elimination. Geneva: WHO; 2023."},{"key":"1866_CR3","volume-title":"Combating Hepatitis B and C to Reach Elimination by 2030","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Combating Hepatitis B and C to Reach Elimination by 2030. Geneva: WHO; 2016."},{"issue":"3","key":"1866_CR4","doi-asserted-by":"publisher","first-page":"e0279972","DOI":"10.1371\/journal.pone.0279972","volume":"18","author":"B Hack","year":"2023","unstructured":"Hack B, Sanghavi K, Gundapaneni S, Fernandez S, Hughes J, Huang S, et al. HCV universal EHR prompt successfully increases screening, highlights potential disparities. PLoS ONE. 2023;18(3):e0279972. https:\/\/doi.org\/10.1371\/journal.pone.0279972.","journal-title":"PLoS ONE"},{"key":"1866_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12879-022-07042-w","volume":"22","author":"LA Kondili","year":"2022","unstructured":"Kondili LA, Andreoni M, Alberti A, Lobello S, Babudieri S, De Michina A, et al. A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions. BMC Infect Dis. 2022;22:58.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"1866_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/liv.14408","volume":"40","author":"LA Kondili","year":"2020","unstructured":"Kondili LA, Gamkrelidze I, Blach S, Marcellusi A, Galli M, Petta S, et al. Optimization of hepatitis C virus screening strategies by birth cohort in Italy. Liver Int. 2020;40(7):1545\u201355. https:\/\/doi.org\/10.1111\/liv.14408.","journal-title":"Liver Int"},{"key":"1866_CR7","unstructured":"World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Geneva: WHO. 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06."},{"key":"1866_CR8","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2022.8609\/2022","author":"DN P\u00e9rez","year":"2022","unstructured":"P\u00e9rez DN, Arraez DM, Rodr\u00edguez IC, Nicol\u00e1s FG, Estevez FD-F, Gonz\u00e1lez AMV, et al. Hepatitis C virus infection screening reduces mortality and is cost-effective independently of the intervention test. Rev Esp Enferm Dig. 2022. https:\/\/doi.org\/10.17235\/reed.2022.8609\/2022.","journal-title":"Rev Esp Enferm Dig"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.epidem.2021.100442","volume":"34","author":"LA Kondili","year":"2021","unstructured":"Kondili LA, Andreoni M, Alberti A, Lobello S, Babudieri S, Roscini AS, et al. Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression. Epidemics. 2021;34:100442. https:\/\/doi.org\/10.1016\/j.epidem.2021.100442.","journal-title":"Epidemics"},{"key":"1866_CR10","unstructured":"Ministero della Salute. Screening, dell\u2019Epatite C. Mar. Available from: https:\/\/www.salute.gov.it\/. Accessed 31 2025."},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.dld.2021.03.026","volume":"54","author":"LA Kondili","year":"2022","unstructured":"Kondili LA, Aghemo A, Andreoni M, Galli M, Rossi A, Babudieri S, et al. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation. Dig Liver Dis. 2022;54:237\u201342.","journal-title":"Dig Liver Dis"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jmv.24635","volume":"89","author":"F Morisco","year":"2017","unstructured":"Morisco F, Loperto I, Stroffolini T, Lombardo FL, Cossiga V, Guarino M, et al. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades. J Med Virol. 2017;89:291\u20137.","journal-title":"J Med Virol"},{"issue":"1","key":"1866_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/microorganisms13010129","volume":"13","author":"G Morsica","year":"2025","unstructured":"Morsica G, Locatelli M, Hernandez-Ibarburu G, Rusconi F, Segovia-Hilara A, Di Napoli D, et al. Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National. Screen Assess Model? Microorganisms. 2025;13(1):129. https:\/\/doi.org\/10.3390\/microorganisms13010129.","journal-title":"Screen Assess Model? Microorganisms"},{"key":"1866_CR14","unstructured":"Grupo de trabajo del estudio de prevalencia de la infecci\u00f3n por hepatitis C en poblaci\u00f3n general en Espa\u00f1a; 2017\u20132018. Resultados del 2\u00ba Estudio de Seroprevalencia en Espa\u00f1a (2017\u20132018). Madrid, Spain: Ministerio de Sanidad, Consumo y Bienestar Social; 2019."},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"107131","DOI":"10.1016\/j.ijid.2024.107131","volume":"146","author":"E Ortega Gonz\u00e1lez","year":"2024","unstructured":"Ortega Gonz\u00e1lez E, Ocete Moch\u00f3n MD, Gimeno Cardona C, Mart\u00ednez-Roma M, Diago Madrid M, G\u00f3mez Mu\u00f1oz N, et al. Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program. Int J Infect Dis. 2024;146:107131. https:\/\/doi.org\/10.1016\/j.ijid.2024.107131.","journal-title":"Int J Infect Dis"},{"key":"1866_CR16","doi-asserted-by":"publisher","unstructured":"Sar\u0131kaya B, Yatar \u0130D, Y\u0131lmaz S, Tiryaki Y, Sar\u0131kaya VA, \u00c7etinkaya RA et al. The usefulness of anti-HCV signal to cut-off ratio in predicting hepatitis C viremia and the effect of genotype differences on signal to cut-off ratio. Rev Assoc Med Bras (1992). 2024;70(8):e20240370. https:\/\/doi.org\/10.1590\/1806-9282.20240370.","DOI":"10.1590\/1806-9282.20240370"},{"issue":"4","key":"1866_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3904\/kjim.2009.24.4.302","volume":"24","author":"YS Seo","year":"2009","unstructured":"Seo YS, Jung ES, Kim JH, Jung YK, Kim JH, An H, et al. Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia. Korean J Intern Med. 2009;24(4):302\u20138. https:\/\/doi.org\/10.3904\/kjim.2009.24.4.302.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"1866_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1665-2681(19)32163-5","volume":"1","author":"S Sookoian","year":"2002","unstructured":"Sookoian S, Casta\u00f1o G. Evaluation of a third generation anti-HCV assay in predicting viremia in patients with positive HCV antibodies. Ann Hepatol. 2002;1(4):179\u201382.","journal-title":"Ann Hepatol"},{"issue":"5","key":"1866_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/fvl-2018-0195","volume":"14","author":"C Mazzarella","year":"2019","unstructured":"Mazzarella C, Rocco C, Vallefuoco L, Sorrentino R, Braschi U, Lauritano G, et al. Differential Reactivity of anti-hepatitis C Virus Screening Assays in Patients With Waning Antibodies. Future Virol. 2019;14(5):303\u20139. https:\/\/doi.org\/10.2217\/fvl-2018-0195.","journal-title":"Future Virol"},{"issue":"7","key":"1866_CR20","doi-asserted-by":"publisher","first-page":"e0219396","DOI":"10.1371\/journal.pone.0219396","volume":"14","author":"S Cammarota","year":"2019","unstructured":"Cammarota S, Citarella A, Manzoli L, Boccia S, De Waure C, La Torre G, et al. The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study). PLoS ONE. 2019;14(7):e0219396. https:\/\/doi.org\/10.1371\/journal.pone.0219396.","journal-title":"PLoS ONE"},{"issue":"3","key":"1866_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"S Blach","year":"2017","unstructured":"Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161\u201376. https:\/\/doi.org\/10.1016\/S2468-1253(16)30181-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1866_CR22","doi-asserted-by":"publisher","unstructured":"Deng Z, Duan L, Wang K. Letter: Addressing Gaps in Hospital-Based Hepatitis C Screening-Insights and Recommendations. Aliment Pharmacol Ther. 2025 Mar;61(5):915\u20136. https:\/\/doi.org\/10.1111\/apt.18460.","DOI":"10.1111\/apt.18460"},{"issue":"4","key":"1866_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/joim.13687","volume":"297","author":"J Weiss","year":"2025","unstructured":"Weiss J, Djekidel M, Hartman T, Mazzone PJ, Lancaster J, Fintelmann FJ. Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals. J Intern Med. 2025;297(4):426\u201338. https:\/\/doi.org\/10.1111\/joim.13687.","journal-title":"J Intern Med"},{"key":"1866_CR24","unstructured":"American Association for the Study of Liver Diseases & Infectious Diseases Society of America. HCV testing and linkage to care. In: HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. HCVGuidelines.org. Updated 27 August 2020. Available from: https:\/\/www.hcvguidelines.org\/guidance\/hcv-testing-and-linkage-to-care\/."},{"issue":"1","key":"1866_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/liv.15746","volume":"44","author":"V Cossiga","year":"2024","unstructured":"Cossiga V, Brusa S, Montalti R, De Conte A, Jannuzzi G, Ranieri L, et al. Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection. Liver Int. 2024;44(1):148\u201354. https:\/\/doi.org\/10.1111\/liv.15746.","journal-title":"Liver Int"},{"issue":"5","key":"1866_CR26","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/v14051096","volume":"14","author":"V Rosato","year":"2022","unstructured":"Rosato V, Kondili LA, Nevola R, Perillo P, Mastrocinque D, Aghemo A, Claar E. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions. Viruses. 2022;14(5):1096. https:\/\/doi.org\/10.3390\/v14051096.","journal-title":"Viruses"},{"issue":"5","key":"1866_CR27","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/v14051096","volume":"14","author":"V Rosato","year":"2022","unstructured":"Rosato V, Kondili LA, Nevola R, Perillo P, Mastrocinque D, Aghemo A, et al. Elimination of Hepatitis C in Southern Italy: A model of HCV screening and linkage to care among hospitalized patients at different hospital divisions. Viruses. 2022;14(5):1096. https:\/\/doi.org\/10.3390\/v14051096.","journal-title":"Viruses"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-026-01866-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-01866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-01866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:22:23Z","timestamp":1781641343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-026-01866-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1186\/s13690-026-01866-7","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (Fortaleza 2013 revision) and approved by the Campania 3 Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as no individual person\u2019s data are presented that would require consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}